Atopic Keratoconjunctivitis: Clinical Trials

6 trials for Atopic Keratoconjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1
Phase 21Unknown 1
Phase 31Recruiting 1

Follow Atopic Keratoconjunctivitis: new trials by email Literature Review of Atopic Keratoconjunctivitis trials Research Report on Atopic Keratoconjunctivitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
DFL24498, Vehicle, dexamethasone sodium phosphate (DSP) ophthalmic solution - Atopic Keratoconjunctivitis
Phase 3RecruitingDompé Farmaceutici S.p.A1532025-12-012026-09-21
Ocular Comorbidity in Atopic Dermatitis
Atopic Keratoconjunctivitis
Active not recruitingCopenhagen University Hospital, Rigshospitalet1202021-08-052024-11-15
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
Dupilumab - Atopic Keratoconjunctivitis
Phase 2UnknownAndover Eye Associates422020-02-102024-01-30
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis
UnknownNational Taiwan University Hospital102018-06-012018-06-14
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
AK002 - Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis
Phase 1CompletedAllakos Inc.302018-02-262019-08-29
Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis
Cyclosporin 0.05% ophthalmic - Atopic Keratoconjunctivitis
Not applicableCompletedJohns Hopkins University122007-08-012018-04-02

Narrower conditions

Conjunctivitis, Allergic (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Keratoconjunctivitis (1)

Broader conditions

Conjunctival Diseases (3)  ·  Conjunctivitis (3)  ·  Eye Diseases (3)  ·  Immune System Diseases (3)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Corneal Diseases (1)  ·  Graft vs Host Disease (1)  ·  Keratitis (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)

Interventions

AK002 (1)  ·  Cyclosporine (1)  ·  Cyclosporins (1)  ·  Ophthalmic Solutions (1)  ·  Vision, Ocular (1)  ·  dexamethasone 21-phosphate (1)  ·  dupilumab (1)

Sponsors

Allakos Inc. (1)  ·  Andover Eye Associates (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  DompĂ© Farmaceutici S.p.A (1)  ·  Johns Hopkins University (1)  ·  National Taiwan University Hospital (1)

Countries

United States (4)  ·  Denmark (1)  ·  Italy (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Esen K Akpek, MD (1)  ·  I-Jong Wang, professor (1)  ·  Quan D Nguyen, MD, MSc (1)  ·  Steffen Heegaard, MD, DMSci (1)

NIH funding

2025 (1)